Cepheid Gets Emergency Use Authorization for Rapid COVID Test
Cepheid received FDA EUA for a rapid molecular diagnostic test for qualitative detection of the virus that causes COVID-19.
Read MorePosted by Andy Lundin | May 13, 2022 | Covid 19, Rapid Assays |
Cepheid received FDA EUA for a rapid molecular diagnostic test for qualitative detection of the virus that causes COVID-19.
Read MorePosted by Andy Lundin | May 12, 2022 | Infectious Diseases, Molecular Diagnostic Analyzers |
BD announced the U.S. launch of its new, fully automated, high-throughput infectious disease molecular diagnostics platform.
Read MorePosted by Andy Lundin | May 12, 2022 | Computing Systems, Covid 19, Rapid Assays |
The Center of BioModular Multi-Scale Systems for Precision Medicine creates rapid tests for human ailments like cancer, stroke, and COVID.
Read MorePosted by Andy Lundin | May 12, 2022 | Covid 19 |
People suffering from long COVID may face an increased risk of abnormal blood clotting, according to a study published in Blood Advances.
Read MorePosted by Andy Lundin | May 10, 2022 | Covid 19, Immunoassay Reagents & test Kits |
Revival Health was awarded as the exclusive distributor of Xiamen Boson Biotech’s Rapid SARS-CoV-2 Antigen Tests following a joint agreement.
Read More